Sign in
Back
745 Developing Precision Medicine in IBD: Peripheral Blood Eosinophilia Identifies Individuals With Worse Outcomes Following Initiation of Anti-TNF Biologic Agents
Journal article   Open access  Peer reviewed

745 Developing Precision Medicine in IBD: Peripheral Blood Eosinophilia Identifies Individuals With Worse Outcomes Following Initiation of Anti-TNF Biologic Agents

Weston Bettner, Andrew Althouse, Claudia Ramos Rivers, Marc Schwartz, Siobhan Proksell, Elyse Johnston, Arthur Barrie, Jana Al Hashash, Janet Harrison, Dmitriy Babichenko, …
The American journal of gastroenterology, Vol.114(1), pp.S437-S437
2019-10
DOI: https://doi.org/10.14309/01.ajg.0000592516.03670.22
url
https://journals.lww.com/ajg/Abstract/2019/10001/745_Developing_Precision_Medicine_in_IBD_.745.aspxView
Published (Version of record) Open

Metrics

7 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.120 Inflammatory Bowel Diseases & Infections
1.120.139 Ulcerative Colitis
Web Of Science research areas
Gastroenterology & Hepatology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details